data_1kb8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kb8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.214 0.531 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.796 0.808 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.678 0.751 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.471 0.653 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.467 0.651 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.532 0.682 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.728 0.775 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.278 0.561 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.723 0.773 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.431 0.634 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.844 0.83 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.615 0.721 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.605 0.717 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.769 0.795 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.653 0.739 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.693 0.758 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.698 0.761 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 CA--C 1.57 1.714 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.583 0.706 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.415 ' H ' ' HD2' ' A' ' 144' ' ' ASP . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.415 ' HD2' ' H ' ' A' ' 130' ' ' ALA . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.586 0.708 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.822 0.82 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.226 0.536 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.757 0.789 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.03 0.443 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 144' ' ' ASP . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.536 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.526 0.679 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.688 0.756 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.708 0.766 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.724 0.773 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.799 0.809 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p -85.31 131.28 34.43 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.962 0.788 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p -85.27 167.17 15.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 123.999 0.812 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p -87.22 160.68 18.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 124.008 0.817 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -87.04 169.33 12.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.026 0.829 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p -87.84 160.5 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.083 0.864 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p -89.53 158.24 17.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.059 0.85 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p -88.72 160.16 17.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.055 0.847 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p -87.26 169.02 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.019 0.824 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p -89.07 140.37 29.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 123.984 0.802 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p -88.64 146.11 25.28 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.992 0.808 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p -87.25 168.21 13.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.052 0.845 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p -87.59 151.44 22.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.195 0.935 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.258 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -86.71 166.09 15.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p -131.19 -176.65 4.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.158 0.911 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p -87.43 169.99 11.76 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.35 156.51 19.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.037 0.836 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -88.51 161.19 17.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.982 0.801 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p -88.05 166.35 14.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.051 0.845 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.97 161.35 17.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.042 0.839 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p -90.12 164.96 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 124.079 0.862 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -93.56 159.13 15.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 124.24 0.962 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p -79.21 -160.5 0.25 Allowed 'General case' 0 CA--C 1.57 1.714 0 O-C-N 123.963 0.789 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p -82.32 171.32 14.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.969 0.793 . . . . 0.0 112.786 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.415 ' H ' ' HD2' ' A' ' 144' ' ' ASP . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.415 ' HD2' ' H ' ' A' ' 130' ' ' ALA . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -88.81 161.0 16.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.017 0.823 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -85.23 165.53 17.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.038 0.836 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p -89.81 154.81 19.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.008 0.818 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.235 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p -87.66 164.19 16.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.009 0.818 . . . . 0.0 112.555 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p -74.73 164.39 26.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.553 0.533 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 144' ' ' ASP . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -87.55 155.83 19.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.044 0.84 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p -87.97 162.99 16.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.978 0.799 . . . . 0.0 112.469 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p -87.81 164.04 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.068 0.855 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p -89.77 160.33 16.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.049 0.843 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p -124.35 -175.44 3.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 124.262 0.977 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.214 0.531 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.796 0.808 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.678 0.751 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.471 0.653 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.467 0.651 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.532 0.682 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.728 0.775 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.278 0.561 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.723 0.773 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.431 0.634 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.844 0.83 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.615 0.721 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.605 0.717 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.769 0.795 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.653 0.739 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.693 0.758 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.698 0.761 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 CA--C 1.57 1.714 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.583 0.706 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 139' ' ' PRO . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 129' ' ' CYS . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.586 0.708 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.822 0.82 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.226 0.536 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.757 0.789 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.03 0.443 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.526 0.679 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.688 0.756 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.708 0.766 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.724 0.773 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.799 0.809 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p -85.31 131.28 34.43 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.962 0.788 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p -85.27 167.17 15.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 123.999 0.812 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p -87.22 160.68 18.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 124.008 0.817 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -87.04 169.33 12.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.026 0.829 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p -87.84 160.5 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.083 0.864 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p -89.53 158.24 17.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.059 0.85 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p -88.72 160.16 17.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.055 0.847 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p -87.26 169.02 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.019 0.824 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p -89.07 140.37 29.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 123.984 0.802 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p -88.64 146.11 25.28 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.992 0.808 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p -87.25 168.21 13.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.052 0.845 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p -87.59 151.44 22.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.195 0.935 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.258 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -86.71 166.09 15.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p -131.19 -176.65 4.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.158 0.911 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p -87.43 169.99 11.76 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.35 156.51 19.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.037 0.836 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -88.51 161.19 17.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.982 0.801 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p -88.05 166.35 14.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.051 0.845 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.97 161.35 17.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.042 0.839 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p -90.12 164.96 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 124.079 0.862 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -93.56 159.13 15.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 124.24 0.962 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p -79.21 -160.5 0.25 Allowed 'General case' 0 CA--C 1.57 1.714 0 O-C-N 123.963 0.789 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p -82.32 171.32 14.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.969 0.793 . . . . 0.0 112.786 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 139' ' ' PRO . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 129' ' ' CYS . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -88.81 161.0 16.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.017 0.823 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -85.23 165.53 17.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.038 0.836 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p -89.81 154.81 19.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.008 0.818 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.235 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p -87.66 164.19 16.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.009 0.818 . . . . 0.0 112.555 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p -74.73 164.39 26.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.553 0.533 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -87.55 155.83 19.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.044 0.84 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p -87.97 162.99 16.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.978 0.799 . . . . 0.0 112.469 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p -87.81 164.04 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.068 0.855 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p -89.77 160.33 16.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.049 0.843 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p -124.35 -175.44 3.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 124.262 0.977 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.214 0.531 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.796 0.808 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.678 0.751 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.471 0.653 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.467 0.651 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.532 0.682 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.728 0.775 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 121.278 0.561 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.723 0.773 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.431 0.634 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.844 0.83 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.615 0.721 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.605 0.717 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.769 0.795 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.653 0.739 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.693 0.758 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.698 0.761 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 CA--C 1.57 1.714 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.583 0.706 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 139' ' ' PRO . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 129' ' ' CYS . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.586 0.708 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.822 0.82 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.226 0.536 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.757 0.789 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.03 0.443 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.526 0.679 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.688 0.756 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.708 0.766 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.724 0.773 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.799 0.809 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.2 p -85.31 131.28 34.43 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.962 0.788 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.7 -83.33 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.347 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.02 104.72 4.22 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 120.248 1.385 . . . . 0.0 109.812 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 m -140.81 -63.77 0.47 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.002 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 68.9 m -107.88 -59.81 1.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.551 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.35 -94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 119.368 0.986 . . . . 0.0 108.779 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -152.09 145.01 24.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 119.969 1.258 . . . . 0.0 110.571 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -26.05 66.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 173.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -70.98 -48.54 52.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.363 0.983 . . . . 0.0 111.891 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -71.11 163.34 66.31 Favored Pre-proline 0 CA--C 1.578 2.029 0 C-N-CA 124.129 0.971 . . . . 0.0 112.777 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.89 143.56 71.29 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.636 2.891 . . . . 0.0 117.447 -174.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -72.71 115.57 12.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.42 50.16 5.86 Favored Glycine 0 CA--C 1.55 2.275 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.112 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 27.9 p -95.71 143.92 26.56 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 117.787 0.793 . . . . 0.0 111.047 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.3 t -78.58 125.69 29.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.041 0.536 . . . . 0.0 111.285 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.006 1.86 . . . . 0.0 107.484 178.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.6 p -85.27 167.17 15.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 123.999 0.812 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.16 -56.69 18.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.19 99.25 11.25 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.83 0.741 . . . . 0.0 109.485 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.3 m -129.54 -69.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.7 m -86.9 134.34 33.53 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.84 90.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.3 138.4 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.1 -38.31 90.31 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -25.56 65.59 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 171.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -74.08 -52.31 13.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.629 1.104 . . . . 0.0 111.801 172.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.42 119.55 77.84 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.793 -1.099 . . . . 0.0 111.107 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -70.43 145.9 54.54 Favored 'Trans proline' 0 CA--C 1.557 1.627 0 C-N-CA 123.142 2.561 . . . . 0.0 113.494 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -71.0 111.66 6.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.522 0.677 . . . . 0.0 110.918 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.72 53.34 8.41 Favored Glycine 0 CA--C 1.55 2.27 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.18 -172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.12 137.31 32.76 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.115 0.958 . . . . 0.0 111.803 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.7 m -92.42 106.85 18.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.202 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.2 p -87.22 160.68 18.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 124.008 0.817 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.7 t -63.44 -44.75 93.62 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.42 100.41 10.87 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.3 t -138.53 -55.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.638 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.7 m -89.11 117.33 28.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.9 95.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.138 0.971 . . . . 0.0 112.027 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -158.26 137.69 11.81 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.93 89.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -69.8 -27.44 64.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -66.57 -52.93 40.15 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.433 1.015 . . . . 0.0 113.019 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -82.64 125.53 75.63 Favored Pre-proline 0 CA--C 1.567 1.63 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.692 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.44 160.05 49.62 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.443 2.762 . . . . 0.0 113.989 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -70.87 111.8 6.57 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.503 0.668 . . . . 0.0 110.95 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.2 7.78 Favored Glycine 0 CA--C 1.55 2.23 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.297 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.4 t -96.92 -68.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.125 0.962 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -93.1 102.94 15.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 122.677 1.227 . . . . 0.0 109.718 -176.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -87.04 169.33 12.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.026 0.829 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.2 t -68.38 -53.03 26.66 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.24 100.35 13.18 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.928 0.786 . . . . 0.0 109.172 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.9 m -130.42 -67.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 50.6 m -81.9 133.19 35.29 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.03 90.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -161.66 128.7 3.93 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -32.11 73.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.96 -42.36 85.32 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.936 0.895 . . . . 0.0 112.706 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.61 -46.85 88.7 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.58 121.91 68.73 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.861 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.38 153.98 69.9 Favored 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.338 2.692 . . . . 0.0 113.648 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -75.01 110.2 9.12 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.46 0.647 . . . . 0.0 109.959 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.27 53.51 6.08 Favored Glycine 0 CA--C 1.55 2.239 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.947 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 t -92.97 149.45 21.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.908 0.854 . . . . 0.0 112.234 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -91.27 115.21 27.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 122.753 1.263 . . . . 0.0 110.586 -179.017 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.5 p -87.84 160.5 17.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.083 0.864 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.9 -49.25 63.03 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.239 -0.886 . . . . 0.0 112.892 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.42 94.74 8.43 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 119.27 0.941 . . . . 0.0 109.012 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.3 m -106.48 -66.47 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.7 m -83.76 126.12 32.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.0 p -80.15 91.28 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.988 0.899 . . . . 0.0 111.028 -174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -155.28 140.01 17.09 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.66 -37.46 84.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -18.75 63.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.95 -52.22 21.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 119.857 1.208 . . . . 0.0 112.845 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.33 138.76 48.35 Favored Pre-proline 0 CA--C 1.569 1.706 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.734 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -62.27 163.65 19.7 Favored 'Trans proline' 0 CA--C 1.561 1.855 0 C-N-CA 123.42 2.747 . . . . 0.0 114.864 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.82 109.85 5.96 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.639 . . . . 0.0 110.186 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.6 54.17 4.73 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.923 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.67 170.58 11.68 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.189 0.994 . . . . 0.0 112.274 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.3 m -73.59 -67.14 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.881 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 124.465 2.079 . . . . 0.0 109.974 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.0 p -89.53 158.24 17.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.059 0.85 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.2 -47.81 78.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.26 95.56 9.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -129.82 -55.19 1.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.848 0.859 . . . . 0.0 109.94 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.1 m -91.55 117.45 29.73 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.26 93.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.982 0.896 . . . . 0.0 111.248 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -156.81 133.88 10.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.93 89.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -28.61 66.55 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 172.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -65.45 -54.49 27.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.524 1.056 . . . . 0.0 112.85 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.55 126.2 71.86 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.591 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.18 160.74 46.04 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 123.32 2.68 . . . . 0.0 114.062 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.26 110.98 7.97 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.358 0.599 . . . . 0.0 110.289 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.29 49.94 13.92 Favored Glycine 0 CA--C 1.55 2.254 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.548 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.0 t -89.07 -69.41 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.117 0.958 . . . . 0.0 110.797 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -71.4 -41.7 69.27 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.115 1.912 . . . . 0.0 110.514 176.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.3 p -88.72 160.16 17.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.055 0.847 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.41 -57.5 6.46 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.233 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.35 110.68 19.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.094 0.861 . . . . 0.0 109.456 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -130.49 -79.18 0.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.3 m -101.45 138.99 37.72 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 m -71.01 85.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 122.312 1.053 . . . . 0.0 112.5 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.92 125.29 1.65 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.76 95.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -26.36 66.46 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -75.4 -51.8 12.24 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.538 1.063 . . . . 0.0 111.817 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.74 140.93 78.47 Favored Pre-proline 0 CA--C 1.57 1.744 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.051 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.42 115.35 2.97 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.446 2.764 . . . . 0.0 113.069 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 115.96 15.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.478 0.656 . . . . 0.0 110.782 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.59 51.39 5.21 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-N 115.133 -0.94 . . . . 0.0 114.416 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -95.65 139.73 31.48 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 117.998 0.899 . . . . 0.0 111.59 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.0 t -86.56 126.04 34.2 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.889 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 124.098 1.904 . . . . 0.0 110.31 -179.395 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.3 p -87.26 169.02 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.019 0.824 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 15.6 t -68.84 -53.94 18.56 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.93 100.82 13.56 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.963 0.801 . . . . 0.0 109.142 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.1 m -130.67 -68.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.6 m -82.61 130.09 35.06 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.46 88.96 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.301 1.048 . . . . 0.0 111.128 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -158.21 133.3 8.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.31 83.88 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -27.83 67.79 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -73.2 -49.48 27.76 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 119.339 0.972 . . . . 0.0 112.142 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.53 123.1 71.56 Favored Pre-proline 0 CA--C 1.566 1.59 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.928 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.79 153.43 73.02 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.322 2.682 . . . . 0.0 113.716 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -74.9 110.22 9.01 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.453 0.644 . . . . 0.0 109.973 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.08 53.37 6.23 Favored Glycine 0 CA--C 1.55 2.237 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.978 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.8 t -92.9 149.69 21.08 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.968 0.884 . . . . 0.0 112.153 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -90.98 114.51 27.03 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 122.74 1.257 . . . . 0.0 110.518 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.295 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.1 p -89.07 140.37 29.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 123.984 0.802 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.28 -69.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.061 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.31 94.49 7.94 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.45 -59.3 2.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.137 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 54.8 m -88.79 -98.67 0.09 Allowed 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.3 84.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -150.97 87.91 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.52 76.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -72.85 -31.87 65.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.18 -56.27 24.26 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.16 0.984 . . . . 0.0 112.936 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -82.66 160.9 60.41 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.68 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.11 127.17 24.92 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.458 2.772 . . . . 0.0 115.41 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.49 114.23 11.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.478 0.656 . . . . 0.0 109.75 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.69 55.19 2.07 Favored Glycine 0 CA--C 1.55 2.274 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.886 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.9 p -114.6 152.93 31.02 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.166 0.987 . . . . 0.0 111.509 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.3 p -79.82 121.22 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.235 0.614 . . . . 0.0 109.769 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 109.525 -177.644 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.4 p -88.64 146.11 25.28 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.992 0.808 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.1 m -75.1 -72.05 0.32 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.028 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.68 97.92 7.48 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.921 1.237 . . . . 0.0 108.03 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -83.67 -63.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.147 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.4 m -85.15 -88.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.03 52.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.047 1.294 . . . . 0.0 110.966 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 99.91 2.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.845 -1.159 . . . . 0.0 108.008 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.17 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -21.49 61.2 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -71.09 -57.26 4.7 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.228 1.376 . . . . 0.0 111.017 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.24 169.04 22.69 Favored Pre-proline 0 CA--C 1.58 2.101 0 C-N-CA 123.856 0.862 . . . . 0.0 110.702 171.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -56.02 110.1 0.52 Allowed 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.505 2.803 . . . . 0.0 115.392 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.52 112.58 16.92 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.91 58.94 2.4 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.982 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.5 p -81.74 153.51 26.48 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.1 m -95.16 96.26 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.009 1.861 . . . . 0.0 106.909 -175.592 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.8 p -87.25 168.21 13.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.052 0.845 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.94 -57.72 10.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.49 99.49 12.33 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.663 0.744 . . . . 0.0 109.541 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -135.25 -68.84 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -87.94 136.1 33.11 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.23 91.83 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.51 93.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.55 72.25 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.84 -46.41 82.02 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.253 0.933 . . . . 0.0 113.307 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.76 116.79 67.25 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.766 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -73.46 153.49 50.02 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.25 2.633 . . . . 0.0 113.939 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -72.81 114.43 10.94 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.601 . . . . 0.0 110.77 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.88 53.55 7.98 Favored Glycine 0 CA--C 1.55 2.231 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.154 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 25.4 p -99.39 153.95 18.59 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.6 m -93.12 122.12 35.17 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 123.987 1.851 . . . . 0.0 108.97 179.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.8 p -87.59 151.44 22.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.195 0.935 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.12 -63.53 1.35 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.518 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.61 106.73 18.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.837 1.199 . . . . 0.0 109.041 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 t -148.11 -63.72 0.26 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.735 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 67.6 m -135.72 130.87 34.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.9 m -72.87 84.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.539 1.161 . . . . 0.0 112.011 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -164.69 122.59 1.69 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.06 86.02 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.8 69.53 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 172.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.55 -51.51 14.43 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 119.29 0.95 . . . . 0.0 112.146 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.7 149.07 85.71 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.652 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.85 130.9 25.77 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 123.157 2.571 . . . . 0.0 113.941 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -76.01 110.21 10.29 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.431 0.634 . . . . 0.0 109.553 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.95 63.78 2.74 Favored Glycine 0 CA--C 1.548 2.153 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.184 -167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 16.7 p -74.59 137.87 42.62 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.7 m -96.13 -66.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 124.025 1.869 . . . . 0.0 108.877 172.441 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.258 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -86.71 166.09 15.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.883 0.849 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.29 -63.17 1.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.475 0.71 . . . . 0.0 111.171 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.68 111.66 22.2 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.173 0.897 . . . . 0.0 109.164 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 m -127.15 -80.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -100.16 144.27 29.38 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 m -74.05 81.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 122.36 1.076 . . . . 0.0 111.716 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -164.44 125.52 2.15 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -38.66 91.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -24.66 64.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 172.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.53 -51.86 10.0 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.607 1.094 . . . . 0.0 111.995 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -74.27 140.82 76.6 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.822 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.31 166.41 9.36 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.463 2.775 . . . . 0.0 115.59 173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.82 116.31 8.35 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.41 0.624 . . . . 0.0 111.224 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.61 51.06 3.77 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.657 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.78 -77.73 0.52 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.087 0.943 . . . . 0.0 109.483 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -98.0 101.7 13.25 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 124.108 1.909 . . . . 0.0 108.545 -176.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.0 p -131.19 -176.65 4.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.158 0.911 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 50.3 t -64.35 -48.95 73.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.41 72.21 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.9 m -69.44 -59.6 2.88 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.197 0.908 . . . . 0.0 111.958 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 74.5 m -83.82 114.59 21.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.35 90.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -155.44 131.29 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.32 93.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -25.18 64.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.57 -46.68 14.09 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 119.733 1.151 . . . . 0.0 113.04 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 140.82 97.41 Favored Pre-proline 0 CA--C 1.571 1.765 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.648 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.46 161.49 17.14 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.572 2.848 . . . . 0.0 115.863 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -71.07 108.77 4.77 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.521 0.677 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.39 52.45 5.17 Favored Glycine 0 CA--C 1.561 2.954 0 CA-C-N 114.707 -1.133 . . . . 0.0 114.978 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 32.8 t -93.14 128.54 39.11 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.474 0.654 . . . . 0.0 109.544 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.0 m -114.74 96.67 5.85 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 122.66 1.219 . . . . 0.0 110.688 -177.67 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.1 p -87.43 169.99 11.76 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.084 0.945 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.8 t -61.44 -51.07 70.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.41 90.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 t -66.08 -44.86 83.23 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.4 m -91.55 109.72 21.02 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.65 86.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.853 0.835 . . . . 0.0 109.124 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -152.44 127.72 9.87 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -26.76 66.18 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -78.84 -49.79 12.35 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 119.539 1.063 . . . . 0.0 112.363 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.79 124.73 90.11 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.727 -174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -64.33 159.91 41.48 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 123.286 2.657 . . . . 0.0 115.264 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -73.56 109.31 6.98 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.596 0.712 . . . . 0.0 110.019 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.63 54.19 6.83 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.786 -171.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 6.6 p -86.66 164.95 16.49 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 117.93 0.865 . . . . 0.0 113.075 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.4 m -85.75 98.13 10.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 124.222 1.963 . . . . 0.0 108.011 -173.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.35 156.51 19.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.037 0.836 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.08 -54.87 20.35 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.02 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.15 94.2 5.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.752 1.16 . . . . 0.0 110.408 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -141.86 -68.98 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 97.7 m -85.73 117.76 24.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 88.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -159.38 118.65 2.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.36 98.49 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.62 63.46 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -63.83 -54.61 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.509 1.05 . . . . 0.0 113.529 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -81.84 151.04 66.95 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-N 119.115 0.87 . . . . 0.0 112.29 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.12 158.88 24.01 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.57 2.847 . . . . 0.0 116.582 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.89 107.3 7.98 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.2 59.65 2.53 Favored Glycine 0 CA--C 1.55 2.244 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.858 -168.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.25 142.24 34.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.6 t -93.52 127.55 39.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 124.055 1.883 . . . . 0.0 109.858 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -88.51 161.19 17.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.982 0.801 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -66.63 -56.54 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.54 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.71 109.54 19.78 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.964 0.802 . . . . 0.0 109.447 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.2 m -130.36 -80.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 135.46 37.91 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.38 87.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.467 1.127 . . . . 0.0 111.846 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -163.69 126.69 2.6 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.64 94.46 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -26.59 66.3 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 172.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.21 -52.17 10.59 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.532 1.06 . . . . 0.0 111.906 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.47 137.97 77.84 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.909 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -63.29 114.88 2.68 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 123.474 2.783 . . . . 0.0 113.148 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -75.47 116.27 16.01 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.424 0.63 . . . . 0.0 110.739 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.29 51.45 4.96 Favored Glycine 0 CA--C 1.55 2.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.299 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.64 133.25 42.43 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.919 0.859 . . . . 0.0 111.286 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.7 m -98.02 105.53 17.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 124.132 1.92 . . . . 0.0 108.348 -177.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.8 p -88.05 166.35 14.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.051 0.845 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.41 -56.69 15.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.07 99.48 12.21 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.669 0.747 . . . . 0.0 109.587 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -134.99 -68.93 0.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 46.0 m -88.45 135.96 33.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.2 t -82.35 91.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -160.86 131.95 5.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.58 93.4 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -31.54 72.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 172.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.85 -46.83 80.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.244 0.929 . . . . 0.0 113.228 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.09 117.1 68.12 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.777 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -73.11 153.98 52.09 Favored 'Trans proline' 0 CA--C 1.56 1.781 0 C-N-CA 123.218 2.612 . . . . 0.0 113.973 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.49 112.89 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.291 0.567 . . . . 0.0 110.101 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.25 53.31 6.18 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.95 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.93 152.09 20.57 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.5 t -91.06 128.66 36.97 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.332 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 122.781 1.276 . . . . 0.0 109.796 -178.843 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -87.97 161.35 17.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.042 0.839 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.22 -46.61 73.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.67 104.8 17.05 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -133.36 -70.92 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 48.8 m -87.07 122.62 31.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.21 94.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.145 0.974 . . . . 0.0 111.716 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -158.63 136.57 10.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.16 96.98 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -27.29 64.9 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 172.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.3 -52.51 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.752 1.16 . . . . 0.0 112.891 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -85.25 125.51 69.82 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.325 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.85 158.83 54.47 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 123.399 2.733 . . . . 0.0 114.145 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -73.24 110.42 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.431 0.634 . . . . 0.0 110.132 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 74.84 53.95 6.11 Favored Glycine 0 CA--C 1.55 2.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.886 -173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.4 t -90.76 -69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 117.963 0.881 . . . . 0.0 111.532 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -121.58 126.31 48.8 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 122.665 1.221 . . . . 0.0 111.643 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.3 p -90.12 164.96 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 124.079 0.862 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.4 t -64.47 -65.18 0.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.092 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.18 108.48 18.94 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.515 1.052 . . . . 0.0 108.807 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -137.36 -52.72 0.67 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.334 0.654 . . . . 0.0 112.19 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.0 m -88.88 161.96 16.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.257 0.935 . . . . 0.0 110.317 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.25 75.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.16 117.01 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.19 89.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -12.49 60.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -80.6 -52.63 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.846 1.203 . . . . 0.0 114.114 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -77.37 157.83 79.99 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.62 159.56 10.95 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 123.763 2.975 . . . . 0.0 116.832 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -69.29 115.52 8.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.313 0.645 . . . . 0.0 110.646 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.03 50.96 3.31 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.34 -174.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 57.5 m -93.65 -75.35 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.086 0.943 . . . . 0.0 109.076 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.9 m -95.98 101.77 13.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 122.665 1.222 . . . . 0.0 109.88 -175.63 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.5 p -93.56 159.13 15.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 124.24 0.962 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.75 -54.7 12.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.614 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.76 105.19 15.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.122 0.874 . . . . 0.0 109.382 175.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -133.99 -73.27 0.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 56.0 m -117.39 133.51 55.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.4 83.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.181 0.991 . . . . 0.0 111.593 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -160.55 125.46 3.77 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.29 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 176.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -40.02 84.81 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 0.0 113.102 172.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -61.2 -51.47 68.87 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.919 0.887 . . . . 0.0 113.347 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -79.12 125.54 83.4 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.66 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.42 157.8 58.52 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 C-N-CA 123.18 2.587 . . . . 0.0 115.776 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -77.05 105.19 7.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.67 65.34 1.62 Allowed Glycine 0 CA--C 1.549 2.18 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.6 p -71.22 146.41 49.05 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -88.98 120.54 30.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 123.99 1.853 . . . . 0.0 107.902 178.187 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.5 p -79.21 -160.5 0.25 Allowed 'General case' 0 CA--C 1.57 1.714 0 O-C-N 123.963 0.789 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.55 -38.04 89.61 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.04 102.48 5.04 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.8 m -135.55 -74.39 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.4 m -127.16 114.08 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.57 97.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.461 1.124 . . . . 0.0 113.496 -169.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.36 124.09 3.11 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -177.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -176.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -33.33 64.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.79 -55.75 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.228 0.922 . . . . 0.0 112.773 176.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.9 mtp-105 -83.72 147.1 51.15 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.024 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.53 123.99 14.53 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.488 2.792 . . . . 0.0 114.078 176.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.82 117.31 13.26 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.439 0.638 . . . . 0.0 111.098 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.03 54.02 3.53 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.94 -174.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.7 p -119.98 151.57 38.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.603 0.761 . . . . 0.0 111.487 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.8 m -95.39 114.19 25.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 124.12 1.914 . . . . 0.0 110.181 178.95 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.6 p -82.32 171.32 14.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.969 0.793 . . . . 0.0 112.786 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 139' ' ' PRO . 52.3 t -59.36 -59.52 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.69 93.08 9.33 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.793 1.179 . . . . 0.0 109.999 176.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.7 m -142.98 -70.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.8 m -93.9 124.93 38.22 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.0 92.8 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.959 0.885 . . . . 0.0 111.122 -175.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -156.64 139.66 15.39 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.57 92.16 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -23.27 64.12 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 171.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -73.57 -49.4 26.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.769 1.168 . . . . 0.0 112.567 176.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -78.66 122.81 85.3 Favored Pre-proline 0 CA--C 1.569 1.699 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.086 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 129' ' ' CYS . 37.1 Cg_exo -69.05 157.42 61.84 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.331 2.687 . . . . 0.0 113.789 174.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.89 111.79 6.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.526 0.679 . . . . 0.0 111.162 -178.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.91 52.43 11.8 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.559 -173.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 9.1 p -89.56 165.36 14.32 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 118.249 1.024 . . . . 0.0 112.861 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -73.83 -60.79 2.09 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.661 -176.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 124.545 2.117 . . . . 0.0 111.503 -176.079 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -88.81 161.0 16.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.017 0.823 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.3 -55.83 16.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.924 176.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.89 108.14 19.03 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.881 0.764 . . . . 0.0 109.546 175.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.4 m -131.87 -78.38 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -177.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.0 m -95.73 132.68 40.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.5 88.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.418 1.104 . . . . 0.0 112.046 -174.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -161.14 123.74 3.14 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.83 97.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -177.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -33.17 74.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.12 -52.55 54.64 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.195 0.907 . . . . 0.0 112.637 173.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.51 135.26 75.52 Favored Pre-proline 0 CA--C 1.569 1.697 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.695 -177.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -59.35 115.62 2.71 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 123.573 2.849 . . . . 0.0 113.87 176.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.68 117.31 17.3 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.654 -172.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 55.22 2.97 Favored Glycine 0 CA--C 1.549 2.206 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.582 -174.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 26.5 p -120.45 152.32 38.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.626 0.77 . . . . 0.0 111.938 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -91.64 109.61 20.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 124.018 1.865 . . . . 0.0 107.834 -178.066 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.9 p -85.23 165.53 17.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.038 0.836 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.4 t -61.87 -43.86 97.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.25 91.61 6.83 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.474 1.034 . . . . 0.0 109.191 174.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.9 m -143.13 -71.04 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 63.2 m -88.99 148.0 24.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.952 0.901 . . . . 0.0 108.569 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.45 86.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.798 0.808 . . . . 0.0 110.126 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -170.57 93.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.39 -36.92 68.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -25.5 68.33 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -60.52 -51.62 68.67 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.338 1.055 . . . . 0.0 113.459 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -84.96 159.07 58.06 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 118.881 0.764 . . . . 0.0 112.042 175.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.98 163.01 10.21 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.708 2.939 . . . . 0.0 117.394 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -75.77 107.83 8.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.36 59.92 2.19 Favored Glycine 0 CA--C 1.55 2.225 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.669 -167.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.2 p -81.91 150.14 27.89 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.7 t -86.84 127.43 35.02 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.678 176.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.785 1.279 . . . . 0.0 109.367 -178.913 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.1 p -89.81 154.81 19.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.008 0.818 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 5.3 t -68.97 -44.42 72.93 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.882 174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.86 92.1 7.75 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.067 0.849 . . . . 0.0 109.563 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.3 m -103.78 -66.96 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.9 m -86.24 119.01 26.06 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.55 91.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -155.7 139.24 15.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.76 72.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -176.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -31.39 70.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 173.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.67 -52.57 56.57 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.999 0.92 . . . . 0.0 113.24 176.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -82.37 124.06 78.45 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.83 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -68.02 162.17 41.09 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 123.287 2.658 . . . . 0.0 114.592 175.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -71.98 113.24 8.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.329 0.585 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.75 56.69 3.48 Favored Glycine 0 CA--C 1.549 2.189 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.308 -172.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 12.0 t -125.8 -60.59 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.375 0.67 . . . . 0.0 111.362 -178.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 m -82.94 112.24 19.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.025 1.869 . . . . 0.0 106.704 -178.831 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.235 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.2 p -87.66 164.19 16.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 124.009 0.818 . . . . 0.0 112.555 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.2 t -61.22 -57.57 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.72 100.9 13.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.789 0.722 . . . . 0.0 109.54 175.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.6 m -129.81 -70.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 49.0 m -89.39 133.69 34.41 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 175.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.72 88.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.053 0.93 . . . . 0.0 110.176 -178.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -157.08 132.26 9.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.7 94.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.9 72.46 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 172.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -65.25 -51.78 58.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.304 0.957 . . . . 0.0 112.62 171.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.9 119.11 75.65 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 117.745 -1.121 . . . . 0.0 110.682 -174.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.37 142.54 41.26 Favored 'Trans proline' 0 CA--C 1.557 1.64 0 C-N-CA 123.127 2.551 . . . . 0.0 113.37 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.36 112.37 7.44 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.601 0.715 . . . . 0.0 110.839 -178.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.42 53.35 7.62 Favored Glycine 0 CA--C 1.549 2.213 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.132 -172.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.9 p -86.36 134.56 33.71 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.121 0.961 . . . . 0.0 111.784 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -99.34 106.28 18.35 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.941 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.8 p -74.73 164.39 26.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.553 0.533 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.7 t -58.16 -62.9 1.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.185 -0.912 . . . . 0.0 112.304 166.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.5 87.12 5.11 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.972 0.891 . . . . 0.0 112.019 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 m -120.79 -75.64 0.59 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 87.8 m -97.79 127.44 43.74 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.279 13.3 p -80.71 88.76 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.051 0.929 . . . . 0.0 112.376 -167.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.28 125.47 6.7 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.32 76.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -175.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.71 77.29 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 167.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -55.13 -49.52 71.57 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 169.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -78.7 141.17 59.69 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.977 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.46 156.47 36.1 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 122.928 2.418 . . . . 0.0 114.651 168.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -96.54 114.31 25.96 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.519 -165.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.62 47.36 49.85 Favored Glycine 0 CA--C 1.549 2.188 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.864 -156.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 10.2 p -87.71 142.78 27.56 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.227 1.013 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.2 m -87.28 171.58 10.51 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-O 123.742 1.734 . . . . 0.0 109.04 174.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -95.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -87.55 155.83 19.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.044 0.84 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.0 t -64.13 -47.54 79.56 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.66 96.98 9.77 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 172.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -132.23 -57.18 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.856 0.862 . . . . 0.0 109.565 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.2 m -89.85 116.53 28.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 174.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.69 95.93 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.516 0.675 . . . . 0.0 109.439 -171.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -157.47 136.98 12.07 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.76 83.29 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 176.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.58 64.05 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 171.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.63 -56.09 4.93 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.698 1.136 . . . . 0.0 111.918 175.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -82.7 128.7 65.23 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.701 -175.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.78 163.0 29.44 Favored 'Trans proline' 0 CA--C 1.561 1.865 0 C-N-CA 123.373 2.715 . . . . 0.0 114.505 172.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -70.65 111.51 6.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.479 0.657 . . . . 0.0 111.016 -179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.72 50.61 18.79 Favored Glycine 0 CA--C 1.551 2.296 0 CA-C-O 118.912 -0.938 . . . . 0.0 114.674 -173.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.7 t -88.68 -67.73 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.255 1.027 . . . . 0.0 110.697 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.6 m -92.17 98.75 11.72 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 175.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -176.189 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 89.3 p -87.97 162.99 16.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.978 0.799 . . . . 0.0 112.469 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.46 -55.82 18.25 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 118.565 -0.731 . . . . 0.0 112.865 176.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.93 103.44 16.15 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.79 0.723 . . . . 0.0 109.345 174.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -122.54 -74.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.4 m -94.1 127.46 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.42 86.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 122.429 1.109 . . . . 0.0 112.262 -172.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -154.8 125.83 7.17 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.73 73.67 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -42.63 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.119 0.872 . . . . 0.0 112.838 173.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.39 -52.53 64.83 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.998 0.919 . . . . 0.0 113.419 173.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -76.39 139.58 68.03 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.115 -174.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -59.42 116.02 2.99 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.623 2.882 . . . . 0.0 113.687 175.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -74.62 117.65 16.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.829 -172.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.24 52.82 3.87 Favored Glycine 0 CA--C 1.549 2.194 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.083 -174.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.7 p -113.8 146.25 40.21 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.771 0.785 . . . . 0.0 111.369 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.6 m -92.25 110.05 21.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 122.67 1.224 . . . . 0.0 109.865 -178.652 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.0 p -87.81 164.04 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.068 0.855 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.1 t -59.79 -60.95 3.03 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.491 175.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.1 82.56 2.74 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.688 0.756 . . . . 0.0 109.393 173.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -84.53 -65.57 0.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.506 0.722 . . . . 0.0 109.21 177.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 95.4 m -107.61 92.55 4.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.81 125.91 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -165.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -135.77 109.82 8.26 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.345 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.92 -27.1 68.58 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -173.525 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -42.47 81.14 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.695 1.134 . . . . 0.0 112.613 172.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -67.3 -55.24 14.7 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 175.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -83.94 154.24 64.15 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-N 118.841 0.746 . . . . 0.0 112.998 -176.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.33 159.67 18.68 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.546 2.831 . . . . 0.0 115.51 172.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.86 108.95 6.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.453 0.644 . . . . 0.0 109.845 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.21 53.42 4.82 Favored Glycine 0 CA--C 1.549 2.214 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.915 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.4 t -86.85 168.19 13.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.179 0.99 . . . . 0.0 111.711 178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 p -76.45 107.96 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.309 0.644 . . . . 0.0 111.156 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 124.037 1.875 . . . . 0.0 109.553 -177.206 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.6 p -89.77 160.33 16.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.049 0.843 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.35 -55.11 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.921 176.078 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.17 109.14 19.67 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.821 0.737 . . . . 0.0 109.472 174.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.1 m -132.14 -78.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.3 m -96.58 133.31 41.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.33 88.87 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.356 1.074 . . . . 0.0 112.133 -174.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -161.66 124.15 3.0 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.531 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.81 97.55 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -33.35 74.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 173.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.23 -52.25 55.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.154 0.888 . . . . 0.0 112.662 173.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -73.81 133.69 79.12 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.419 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.68 115.75 2.89 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.485 2.79 . . . . 0.0 113.918 178.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -76.34 117.24 17.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.648 -172.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.13 54.08 3.69 Favored Glycine 0 CA--C 1.549 2.215 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.794 -174.278 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 29.0 p -111.73 147.11 36.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.569 0.748 . . . . 0.0 112.121 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.0 m -97.53 105.57 17.74 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.791 1.282 . . . . 0.0 107.608 -177.639 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.4 p -124.35 -175.44 3.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 124.262 0.977 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.0 t -64.13 -59.3 4.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 112.709 176.268 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.05 85.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 176.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.9 m -69.24 -59.17 3.19 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.592 1.087 . . . . 0.0 111.588 178.211 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.9 m -87.3 107.61 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.44 88.88 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.73 0.776 . . . . 0.0 108.962 -178.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -152.55 129.43 10.97 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.98 91.07 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.278 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -27.29 66.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 172.521 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -79.51 -47.44 15.58 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.413 1.006 . . . . 0.0 112.722 175.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -65.32 148.14 98.16 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.71 166.27 10.32 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.467 2.778 . . . . 0.0 114.768 171.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -69.36 109.43 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.606 -178.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.67 49.11 7.4 Favored Glycine 0 CA--C 1.55 2.245 0 CA-C-O 118.475 -1.18 . . . . 0.0 114.988 -174.198 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 49.7 t -112.76 132.6 55.16 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 110.116 176.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -105.31 167.19 9.89 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.029 178.695 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.923 1.82 . . . . 0.0 109.518 177.679 . . . . . . . . 0 0 . 1 stop_ save_